Medios AG has signed an agreement to acquire 74% of the shares in Caesar & Loretz GmbH (Caelo), subject to antitrust approval. Caelo, headquartered in Hilden, is a leading supplier of pharmaceutical active ingredients (APIs), excipients, and raw materials...
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Medios AG has signed an agreement to acquire 74% of the shares in Caesar & Loretz GmbH (Caelo), subject to antitrust approval. Caelo, headquartered in Hilden, is a leading supplier of pharmaceutical active ingredients (APIs), excipients, and raw materials...